Akmal Iuldashev

Akmal Iuldashev


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2025 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
FYF.A. Yusupov
F.A. Yusupov
AIAkmal Iuldashev
Akmal Iuldashev
MAM.SH. Abdykadyrov
M.SH. Abdykadyrov
TYT.F. Yusupova
T.F. Yusupova
Numerous studies showed an association between Parkinson’s disease and low uric acid levels. Low uric acid levels are associated with an increased risk of Parkinson’s disease, its progression, and the severity of symptoms. Although the biological mechanisms for this association have not yet been established, it is suggested that uric acid acts as an antioxidant, reducing oxidative stress and protecting dopaminergic neurons. However, some recent studies question this hypothesis. The article discusses the biological properties of uric acid, its relationship to Parkinson’s disease, and the possibility of reverse causation, where the disease causes a decrease in uric acid levels. The presented data support further research to understand these relationships more deeply, possibly leading to new disease treatment approaches.

15 September 2021 in Bulletin of Science and Practice
Verified
Journal Article
Open access
FYF. Yusupov
F. Yusupov
AIAkmal Iuldashev
Akmal Iuldashev
The proportion of neurodegenerative diseases among all neurological disorders is growing year after year. This is explained by the duration of the latency period and the manifestation of signs after the death of about 40–60% of neurons. According to WHO forecasts, neurodegenerative diseases will be the biggest problem in the healthcare system of the XXI century. Among them, the most acute can be considered Alzheimer’s and Parkinson’s diseases. Specific biomarkers of neurodegenerative diseases (diseases: Alzheimer’s; Parkinson’s; Huntington’s) are discussed. Currently, the highest priority in neurology is the identification of specific biomarkers in the blood serum for each nosology. In medicine, less invasive, atraumatic methods are always encouraged, therefore, the detection of biomarkers in the blood has advantages over the detection in the cerebrospinal fluid, the production of which is more invasive. The review examines the biomarkers of Alzheimer’s, Parkinson’s and Huntington’s diseases.

15 July 2024 in Bulletin of Science and Practice
Verified
Journal Article
Closed access
FYF. Yusupov
F. Yusupov
AIAkmal Iuldashev
Akmal Iuldashev
TNT. Nurmatov
T. Nurmatov
The World Health Organization (WHO) has stated that neurodegenerative diseases will be the biggest health problem in the future. Among neurodegenerative diseases, Parkinson’s disease is the second most common after Alzheimer’s disease. Parkinson’s disease (PD) is the most common pathology of a person with movement disorders. Among neurological diseases, it has a high social significance due to the negative effect on the quality of life (early loss of the ability to work, progressive disorders of motor and cognitive skills). With increasing life expectancy, the prevalence of Parkinson’s disease increases. Biological markers of early diagnosis of Parkinson’s disease are being actively studied. The review presents the most clinically significant biological markers for the preclinical diagnosis of Parkinson’s disease. Biomarkers of cerebrospinal fluid, serum biomarkers and biomarkers of other biological fluids in Parkinson's disease are discussed.

1 January 2022 in Practical medicine
Verified
Journal Article
Closed access
OUOsh State University
Osh State University
FYF. A. Yusupov
F. A. Yusupov
AIAkmal Iuldashev
Akmal Iuldashev
GOG. M. Ormonova
G. M. Ormonova
MAM. Sh. Abdykadyrov
M. Sh. Abdykadyrov
The article presents a review of the literature on the syndrome of posterior reversible leukoencephalopathy. The syndrome of posterior reversible leukoencephalopathy is characterized by a spectrum of neurological and radiological features. The factors are reflected which contribute to the syndrome development, clinical manifestations, radiological signs, mechanisms of development, diagnosis, differential diagnosis, treatment, prognosis, course and outcome in this pathology. A clinical case of the development of reversible posterior leukoencephalopathy syndrome in a patient with newly diagnosed HIV infection is presented.

6 June 2023 in Nephrology (Saint-Petersburg)
Verified
Journal Article
Closed access
PDF file
FYF. A. Yusupov
F. A. Yusupov
AIAkmal Iuldashev
Akmal Iuldashev
In physiological states, the nervous system and kidneys interact with each other to maintain normal homeostasis in the body. However, pathological conditions such as hypertension, pathology of the kidney itself, both acute and chronic, disrupt this interaction. In acute kidney injury (AKI of various etiologies) and chronic kidney disease (CKD), damaged kidneys can have a significant impact on the function of the central nervous system. CKD is an independent risk factor for the development of cerebrovascular diseases and cognitive impairment due to many factors, including the retention of uremic toxins and phosphates, have been proposed as CKD-specific factors responsible for structural and functional cerebral changes in patients with CKD, however, additional studies are needed to determine the exact pathogenesis. Our review is devoted to the interaction of the kidney and the nervous system in physiological conditions and pathophysiological conditions, we are trying to reveal in detail the mechanisms of dysfunction of the nervous system in kidney pathologies.

15 November 2025 in Urology Herald
Verified
Journal Article
Closed access
FYF. A. Yusupov
F. A. Yusupov
AYA. F. Yusupov
A. F. Yusupov
AIAkmal Iuldashev
Akmal Iuldashev
Chronic kidney disease (CKD) is the most significant risk factor in the development of stroke; the latter remains the leading cause of morbidity and mortality globally. CKD patients, especially at the end-stage renal failure and on dialysis, have a very high risk of stroke by 5 – 30 times, with a mortality rate reaching almost 90%. CKD is associated with both ischemic and hemorrhagic stroke. In addition to general risk factors, increased cerebrovascular risk is due to several mechanisms associated with CKD, such as platelet dysfunction, blood clotting disorders, endothelial dysfunction, inflammation, and an increased risk of atrial fibrillation. In addition, CKD can significantly affect the effectiveness of stroke treatment and prevention. Therefore, it is important to study the factors contributing to the development of stroke in this vulnerable population group to apply preventive strategies more effectively. This article examines the epidemiology and pathophysiology of the association between CKD and stroke, as well as the impact of CKD on stroke outcomes. The study aimed to review scientific articles published over the past twenty years on the relationship between CKD and stroke risk. To achieve this objective, a search was used for the keywords «chronic kidney disease», «stroke», «risk», «stroke risk factors» in the databases PubMed, Google Scholar and eLibrary.